Endotherapy Devices Market by Type (Needles, Biopsy Forceps, Balloon Dilators, Haemostasias, Snares, Catheters, Sphincterotomes, Guide Wires, Stents, Retrieval Net), Application (Upper GI Endoscopy, Colonoscopy, Cystoscopy)

Description

List of Tables

Endotherapy Devices Market Size, Share, Forecast, & Trends Analysis by Type (Needles, Biopsy Forceps, Balloon Dilators, Haemostasias, Snares, Catheters, Sphincterotomes, Guide Wires) Application (Upper GI Endoscopy, Colonoscopy)-Global Forecast to 2030

The global endotherapy devices market is expected to reach $7 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the endotherapy devices market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global endotherapy devices market is mainly attributed to the rising rate of diseases requiring endoscopic procedures, the rising prevalence of gastrointestinal conditions, increasing patient preference for minimally invasive procedures, the rising geriatric population, and technological advancements in endotherapy devices. However, the high cost of endotherapy devices and the risk of infections caused by some devices restrain the growth of this market. The growing demand for endotherapy devices in emerging economies is expected to generate growth opportunities for the players operating in this market. However, the shortage of trained physicians is challenging market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the global endotherapy devices market are Boston Scientific Corporation (U.S.), Olympus Corporation (Japan), Medtronic plc (U.S.), FUJIFILM Holdings Corporation (Japan), Cook Group Incorporated (U.S.), Conmed Corporation (U.S.), Hoya Corporation (Japan), Stryker Corporation (U.S.), KARL STORZ SE & Co. KG (Germany), Smith & Nephew PLC (U.K.), Micro-Tech (Nanjing) Co., Ltd. (China), Nipro Corporation (Japan), MEDIVATORS B.V. (Germany), The Cooper Companies, Inc. (U.S.), and Johnson & Johnson (U.S.)

Among all the types studied in this report, the global endotherapy devices market is segmented into endotherapy needles devices, biopsy forceps, balloon dilators, hemostasis systems, hemoclips, snares, catheters, sphincterotomes, guide wires, extraction balloons, extraction baskets, stents, distal caps, polyp retrieval traps, retrieval net, and other devices. The stents segment is projected to register the highest CAGR during the forecast period. Endoscopic stents are used to treat several illnesses, such as primary sclerosing cholangitis, metastatic disease, and pancreaticobiliary malignancy. Factors such as an inclination toward minimally invasive endoscopic stenting, the rising number of diseases requiring endoscopic stenting, and a preference for endoscopic stenting over balloon dilation are driving the market growth.

Among all the applications studied in this report, the global endotherapy devices market is segmented into upper gastrointestinal (GI) endoscopy, colonoscopy, cystoscopy, bronchoscopy, laryngoscopy, and other applications. In 2023, the upper GI endoscopy segment is expected to account for the largest share of the market. The large market share of this segment is mainly attributed to the use of endotherapy devices in performing various GI procedures, The use of endotherapy devices in upper gastrointestinal endoscopy for treating diseases such as stomach ulcers, and the preference for minimally invasive procedures.

An in-depth analysis of the geographical scenario of the global endotherapy devices market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the endotherapy devices market. The large market share of this region can be attributed to the high awareness of endoscopic procedures, technological advancements in endotherapy, the increasing prevalence of chronic diseases, and the increasing preference for minimally invasive surgeries.

Scope of the Report:

Endotherapy Devices Market Assessment-by Type

Endotherapy Needle Devices
- Fine Needle Biopsy (FNB) System
- Fine Needle Aspiration (FNA) System
- Fine Needle Fiducial (FNF) System
Biopsy Forceps
- Single-use Biopsy Forceps
- Reusable Biopsy Forceps
Balloon Dilators
Haemostasis System
Hemoclips
Snares
Catheters
- Dilatation Catheters
- Ureteral Catheters
- Coronary Catheters
Sphincterotomes
Guide Wires
Extraction Balloons
Extraction Baskets
Stents
- Metal Stents
- Plastic Stents
Distal Caps
Polyp Retrieval Traps
Retrieval Net
Other Devices

(Other devices include Cleaning Brushers, Endoscope Protectors, Biopsy Valves, ESD Knife, Injection Needles, and Handpieces)

Endotherapy Devices Market Assessment-by Application

Upper Gastrointestinal (GI) Endoscopy
Colonoscopy
Cystoscopy
Bronchoscopy
Laryngoscopy
Other Applications

Other applications include neuroendoscopy, laparoscopy, and arthroscopy

Endotherapy Devices Market Assessment-by Geography

North America
U.S.
Canada
Europe
U.K
Germany
France
Italy
Spain
Rest of Europe (Roe)
Asia-Pacific (APAC)
China
Japan
India
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Rest of Latin America (RoLATAM)
Middle East & Africa

Product Code: MRHC - 104845

1. Market Definition & Scope

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Process
2.2. Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
2.3. Market Assessment
- 2.3.1. Market Estimation
  - 2.3.1.1. Bottom-up Approach
  - 2.3.1.2. Top-down Approach
  - 2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Increasing Preference for Minimal Invasive Procedures
- 4.2.2. Rising Prevalence of Gastrointestinal Conditions
- 4.2.3. Technological Advancements in Endotherapy Devices
4.3. Restraints
- 4.3.1. High Cost of Endoscopy Procedures
- 4.3.2. Risk of Infection by Endotherapy Devices
4.4. Opportunities
- 4.4.1. Increasing Demand for Endoscopy Procedures in Emerging Economies
4.5. Challenges
- 4.5.1. Lack of Skilled Professionals
4.6. Regulatory Analysis
4.7. Pricing Analysis
4.8. Porter's 5 Force Analysis

5. Endotherapy Devices Market Assessment-Type

5.1. Overview
5.2. Endotherapy Needle Devices
- 5.2.1. Fine Needle Biopsy (FNB) System
- 5.2.2. Fine Needle Aspiration (FNA) System
- 5.2.3. Fine Needle Fiducial (FNF) System
5.3. Biopsy Forceps
- 5.3.1. Single-use Biopsy Forceps
- 5.3.2. Reusable Biopsy Forceps
5.4. Balloon Dilators
5.5. Hemostasis System
5.6. Hemoclips
5.7. Snares
5.8. Catheters
- 5.8.1. Dilatation Catheters
- 5.8.2. Ureteral Catheters
- 5.8.3. Coronary Catheters
5.9. Sphincterotomes
5.10. Guide Wires
5.11. Extraction Balloons
5.12. Extraction Baskets
5.13. Stents
- 5.13.1 Metal Stents
- 5.13.2 Plastic Stents
5.14. Distal Caps
5.15. Polyp Retrieval Traps
5.16. Retrieval Nets
5.17. Other Devices

6. Endotherapy Devices Market Assessment-by Application

6.1. Overview
6.2. Upper Gastrointestinal (GI) Endoscopy
6.3. Colonoscopy
6.4. Cystoscopy
6.5. Bronchoscopy
6.6. Laryngoscopy
6.7. Other Applications

7. Endotherapy Devices Market Assessment-by Geography

7.1. Overview
7.2. North America
- 7.2.1. U.S.
- 7.2.2. Canada
7.3. Europe
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Rest of Europe (RoE)
7.4. Asia-Pacific
- 7.4.1. Japan
- 7.4.2. China
- 7.4.3. India
- 7.4.4. Rest of Asia-Pacific (RoAPAC)
7.5. Latin America
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America (RoLATAM)
7.6. Middle East and Africa

8. Competition Analysis

8.1. Overview
8.2. Competitive Dashboard
- 8.2.1. Industry Leaders
- 8.2.2. Market Differentiators
- 8.2.3. Vanguards
- 8.2.4. Emerging Companies
8.3. Vendor Market Positioning
8.4. Market Share Analysis/Market Ranking (2022)

9. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, SWOT Analysis)

9.1. Boston Scientific Corporation
9.2. Olympus Corporation
9.3. Medtronic plc
9.4. FUJIFILM Holdings Corporation
9.5. Cook Group Incorporated
9.6. Conmed Corporation
9.7. Hoya Corporation
9.8. Stryker Corporation
9.9. KARL STORZ SE & Co. KG
9.9. Smith & Nephew PLC
9.11. Micro-Tech (Nanjing) Co., Ltd.
9.12. Nipro Corporation
9.13. MEDIVATORS B.V.
9.14 The Cooper Companies, Inc.
9.15 JOHNSON & JOHNSON

10. Appendix

10.1. Available Customization
10.2. Related Reports